These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 8761381)
21. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells. Schlager S; Speck SH; Woisetschläger M J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690 [TBL] [Abstract][Full Text] [Related]
22. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Chen H; Smith P; Ambinder RF; Hayward SD Blood; 1999 May; 93(9):3026-32. PubMed ID: 10216099 [TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440 [TBL] [Abstract][Full Text] [Related]
24. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice. Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010 [TBL] [Abstract][Full Text] [Related]
25. [Studies on tissue distribution and expression of Epstein-Barr virus using polymerase chain reaction]. Oikawa O Hokkaido Igaku Zasshi; 1995 Sep; 70(5):729-42. PubMed ID: 8543279 [TBL] [Abstract][Full Text] [Related]
26. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944 [TBL] [Abstract][Full Text] [Related]
27. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. Chen F; Zou JZ; di Renzo L; Winberg G; Hu LF; Klein E; Klein G; Ernberg I J Virol; 1995 Jun; 69(6):3752-8. PubMed ID: 7745723 [TBL] [Abstract][Full Text] [Related]
28. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection. Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278 [TBL] [Abstract][Full Text] [Related]
29. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells. Doyle MG; Crawford DH Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878 [TBL] [Abstract][Full Text] [Related]
30. A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA. Majerciak V; Yang W; Zheng J; Zhu J; Zheng ZM J Virol; 2019 Jan; 93(2):. PubMed ID: 30355690 [TBL] [Abstract][Full Text] [Related]
31. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717 [TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
33. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. Kis LL; Takahara M; Nagy N; Klein G; Klein E Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314 [TBL] [Abstract][Full Text] [Related]
34. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. Martel-Renoir D; Grunewald V; Touitou R; Schwaab G; Joab I J Gen Virol; 1995 Jun; 76 ( Pt 6)():1401-8. PubMed ID: 7782768 [TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607 [TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. Kelly GL; Milner AE; Tierney RJ; Croom-Carter DS; Altmann M; Hammerschmidt W; Bell AI; Rickinson AB J Virol; 2005 Aug; 79(16):10709-17. PubMed ID: 16051863 [TBL] [Abstract][Full Text] [Related]
37. Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression. Yoshiyama H; Shimizu N; Takada K EMBO J; 1995 Aug; 14(15):3706-11. PubMed ID: 7641689 [TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus: 40 years on. Young LS; Rickinson AB Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157 [TBL] [Abstract][Full Text] [Related]